Become a Member

Track your favourite stocks
Create & monitor portfolios
Daily portfolio value

Company	Chg	Chg %
Quickpicks
£	%
Add shares to your quickpicks to display them here!

Avacta Group (AVCT) Share News

Avacta Group Launches New OPTIM Variants As It seeks new Customers

4th Aug 2014 08:54

UK MIDDAY BRIEFING: Smith & Nephew Confident In Outlook

1st Aug 2014 10:58

UK WINNERS & LOSERS: Smith & Nephew, Rexam Lead Few FTSE 100 Risers

1st Aug 2014 10:36

Avacta Group Falls On Sensipod Delays, North America Problems

1st Aug 2014 08:22

Avacta Appoints Cosmo Bio As Japanese Distributor For Affimers

15th Jul 2014 10:08

UK BROKER RATINGS: Morgan Stanley Cuts SABMiller To Equal-Weight

4th Jun 2014 09:07

LONDON (Alliance News) - The following UK shares received analyst recommendations Wednesday morning: ---------- FTSE 100 ---------- NOMURA RAISES REED ELSEVIER PRICE TARGET TO 1050 (975) PENCE - 'BUY' ---------- CITIGROUP CUTS TULLOW OIL PRICE TA Read More

Avacta Gets Funding Award To Support Affirmer Development

2nd Jun 2014 09:04

LONDON (Alliance News) - Avacta Group PLC Monday said it had secured a funding award from the UK's innovation agency to support it in developing affirmer technology as a potential way of helping develop new cancer treatments. The company is developing affimers, which are engineered alternat Read More

Avacta In Collaboration Deal With UbiQ To Develop Ubiquitin Reagents

9th May 2014 10:34

LONDON (Alliance News) - Avacta Group PLC Friday said it has signed a collaboration deal with ubiquitylated peptides supplier UbiQ Bio under which the companies will work together to develop reagents that specifically bind to ubiquitin chains. Avacta makes diagnostic tools, consumables and Read More

REPEAT: Avacta Raises GBP10.1M In Placing With Additional Option

7th May 2014 10:18

LONDON (Alliance News) - Avacta Group PLC Wednesday said it has raised GBP10.1 million before expenses through a share placing on 918.2 million shares, which it will use to accelerate the development and commercialisation of Affimers. The shares were placed with both new and existing instit Read More

Avacta Raises GBP10.1M In Share Placing With Additional Option

7th May 2014 10:16

Avacta Loss Narrows, Boosted By Sales Of Analytical Instrument Optim

23rd Apr 2014 12:13

LONDON (Alliance News) - Avacta Group PLC Wednesday posted a narrowed pretax loss for the year to end-January, boosted by increased sales of its analytical instrument Optim. The biotechnology company posted a pretax loss of GBP500,000, narrowed from GBP807,000 in the previous year, as reven Read More

UK Earnings, Trading Statements Calendar - Week Ahead

23rd Apr 2014 05:08

UK Earnings, Trading Statements Calendar - Week Ahead

22nd Apr 2014 15:39

UK Earnings, Trading Statements Calendar - Week Ahead

22nd Apr 2014 05:12

UK Earnings, Trading Statements Calendar - Week Ahead

17th Apr 2014 15:19

UK Earnings, Trading Statements Calendar - Week Ahead

17th Apr 2014 05:16

CORRECT: UK Earnings, Trading Statements Calendar - Week Ahead

16th Apr 2014 16:02

(An item published at 1615 GMT, incorrectly said Taylor Wimpey was issuing a statement April 17. The correct version follows.) <table border="0" frame="VOID" rules="NONE" cellspacing="0"><colgroup><col width="403" /><col width="256" /></colgroup><tbody><tr><td align="LEFT" Read More

UK Earnings, Trading Statements Calendar - Week Ahead

16th Apr 2014 15:15

Avacta Launches Pancreatitis Test For Dogs

14th Apr 2014 07:06

LONDON (Alliance News) - Avacta Group PLC said Monday it has completed development and validation of a new test for pancreatitis in dogs. The provider of proprietary diagnostic tools, consumables and reagents for human and animal healthcare said the new test uses an algorithm to combine the Read More

Avacta Notes Positive Development Progress For Affirmers

20th Mar 2014 12:51

LONDON (Alliance News) - Avacta Group Thursday said it has achieved certain technical milestones towards commercial progress regarding its commercialisation of Affirmer reagents for life sciences research. Affimer reagents are engineered alternatives to antibodies designed to address many o Read More

FTSE 100 Latest

Value9,479.14

Change-12.11